目的：对比观察睫状体冷凝联合复合式小梁切除术与单用睫状体冷凝技术治疗绝对期新生血管性青光眼(neovascular glaucoma, NVG)的临床效果。 方法：收集我院2012-02/2013-06间收治的82例绝对期新生血管性青光眼病例。随机分为观察组和对照组,各41例。对照组给予睫状体冷凝术治疗；观察组患者给予睫状体冷凝联合复合式小梁切除术治疗。对两组术后视力、眼压和并发症进行观察。 结果：观察组患者术后6mo 视力提高率为61.0%,显著性高于对照组(41.5%),差异有统计学意义(χ2=3.843,P =0.018)；观察组患者术后眼压显著性低于对照组,差异有统计学意义(P0.05)。 结论：相比于单用睫状体冷凝术,睫状体冷凝联合复合式小梁切除术治疗 NVG 具有降眼压效果好、术后并发症少、成功率高的优点,值得推广。%To investigate the clinical efficacy of cyclocryotherapy combined trabeculectomy and single cyclocryotherapy for neovascular glaucoma (NVG). ●METHODS:Totally 82 patients with NVG from February 2012 to June 2013 in our hospital were selected and randomly divided into observation group and control group, each 41 cases. Patients in control group were given single cyclocrytherapy, and patients in observation group were given cyclocryotherapy combined trabeculectomy. The visual acuity, intraocular pressure and postoperative complications of two groups were observed. ●RESULTS: After postoperative six months, the improvement rate of visual acuity in observation group was 61. 0%, which was significantly higher than that of control group ( 41. 5%), the difference was statistically significant (χ2 = 3. 843, P = 0. 018). lntraocular pressure of observation group was significantly lower than that of control group, the difference was statistically significant (P0. 05). ●CONCLUSlON: Compared with single cyclocryotherapy, cyclocryotherapy combined trabeculectomy has advantages of low intraocular pressure, less postoperative complications, and high success rate, so it is worthy of promotion.
展开▼
